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Innovation is the lifeblood of contemporary surgery, especially cardiotho-racic surgery. Our most revered mentors and exemplars of excellenceachieved their greatness in large measure through their innovative contribu-tions to our surgical art and science. Their contributions were made in thespirit of advancing the care of surgical patients. In earlier times, the possi-bility of profit was not an important incentive for innovation.
But times are changing. In the past several decades, the business side of medi-
cine, which has always been present, has risen to a new prominence among the con-
cerns of surgeons. In part, this has been related to environmental change: efforts to
control costs through managed care have resulted in substantially lower incomes,
and younger surgeons now start their practices with high levels of indebtedness.
Both factors provide incentives for surgeons to seek additional sources of income.
Another impetus toward increased focus on business is the development of new sur-
gical technologies. As technologies have become more sophisticated, the potential
for profiting from them has grown substantially; often, millions of dollars will be
made from new inventions and techniques. For many surgeons, business ethics has
overtaken, and in some cases, supplanted professional ethics. 
I do not speak pejoratively of business ethics. I have little patience with those
who reduce business ethics to caveat emptor and then easily knock down that straw
man to demonstrate the superiority of professional ethics. In my view, we should
respect business ethics in its best expression, much as we view our own professional
ethics as an aspirational ideal.1
Business has a central goal, a characteristic that distinguishes it from charities,
governments, country clubs, and all other human activities: to maximize the value
of the business to the owners over the long term by trading goods and services.
Achieving that goal requires businessmen to act in certain ways, most importantly
with honesty and promise keeping, for such actions generate the confidence in
future transactions that is the foundation of future growth and value of a business.
Businessmen act ethically when they maximize long-term value for owners under
conditions of ordinary decency, including honesty and keeping promises.2
Companies work to maximize profits, and this incentive has led directly to the
creation of new technologies, which in turn have led to improvements in health, to
better quality of life, and to longer life spans in capitalist countries. Not only is the
profit motive admirable, it has been demonstrated over and over to be a powerful
force for good. It leads to advances that benefit everyone. Compare, for example,
standards of living, quality of life, and longevity in 1901 with those in 2001, at
every socioeconomic level. Most of those gains have been due to human ingenuity
at work in free markets, with money as the incentive for innovation. 
Is there some reason why surgeons should act differently from businessmen? The
principle of optimizing profits is proper for business, for good reason, but it is not
appropriate for physicians. Our ethics—the way we ought to behave in our profes-
sional lives—are driven by an imperative that arises from the nature of what we do.
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The goal of medicine is not to maximize profits, but to serve
the patient’s interests. Good physicians differ from other
professionals in one critically important way: our need to
efface self-interest to serve primarily the patient’s interests.3
There is an important, fundamental reason for this spe-
cial requirement of physicians. To achieve our professional
goal, the good of the patient, we need access to information
about the patient that he may be unwilling to give to anyone
else. People may share certain confidences with their attor-
neys, with their accountants, or with their ministers. But
none of these confidences are as widely ranging and deeply
personal as those that must be shared with their physicians.
This unparalleled need for intimate knowledge of patients is
magnified in the case of surgeons. We need not only histor-
ical and current information about the patients, but also
access to the interior of their bodies at a time when they are
completely helpless, under anesthesia. The intimacy of the
information about the patient needed by the surgeon in
combination with the extraordinary vulnerability of the
body at the time of surgery demands the highest attainable
level of trust by the patient in the physician. This require-
ment for intimacy at many levels makes fidelity to the
patient’s interests the paramount ethical guide for physi-
cians. Patients will provide their surgeons with all of the
critical information needed for appropriate care and will
allow access to the interiors of their bodies only if they can
fully trust that the surgeon will always act in the patient’s
interest. This overarching trust lies at the heart of the heal-
ing relationship and is the core of our professionalism.1
Surgeons can benefit personally from the development of
new surgical technologies in several ways: for example, by
owning a company or its stock, by accepting gifts that are
intended to influence the use of new products, and by
accepting paid vacations, sometimes on the pretext of “doing
research.” Each of these may deflect physicians’ focus from
their patients’ interests to their own and therefore represent
potential conflicts of interest. Conflicts of interest are ubiq-
uitous and unavoidable. For example, we make our living by
charging fees for what we do, and we could make medical
decisions on the basis of maximizing income rather than
serving the interests of patients. Such conflicts are not nec-
essarily wrong in themselves; the potential for harm comes
from how we resolve them, and for physicians, they must
always be resolved in the patient’s favor.4
Therefore, it could be argued, when we have an opportu-
nity to benefit personally from development of new prod-
ucts, it would seem that we stand on firm ethical ground if
we simply do not allow those benefits to influence our obli-
gations to our patients. The fatal flaw in this view is the
human capacity for self-deception. We easily convince our-
selves that, although we have conflicts of interest, we will
always resolve them in favor of our patients. We justify own-
ership of device companies, in whole or in part, by claiming
that potential profits have not and will not affect the patient-
care decisions we make. This is largely self-delusion; patient
care often is affected by biases induced by connections with
industry. We accept substantial gifts from industry, convinc-
ing ourselves they have no influence on patient-care deci-
sions, even though there is a good deal of evidence to the
contrary.5 We tell ourselves that continuing medical educa-
tion activities sponsored by companies have no influence on
patient-care decisions we make when, in fact, much evi-
dence suggests that such influence is pervasive.6,7 Many of
us adjust diagnoses or procedure codes for insurance billing
purposes, telling ourselves that we are doing it only for the
patient’s benefit; clearly, though, we also benefit ourselves
by assuring collection of our fees.8,9 Several spectacular
recent cases linking physicians’ ownership of stock with
harms to patients as research subjects have made national
front page news: for example, deaths associated with
Protocol 126 at the Fred Hutchinson Cancer Institute,10 a
gene transfer experiment gone awry at the University of
Pennsylvania,11 and premature deployment of the HeartPort
technique for cardiac surgery.12 The physicians in those
cases did not mean to cause harm, but inappropriate profit
motive played a role in doing just that. We must recognize
the human capacity for self-deception and accept that none
of us is immune from its insidious expression. 
There is no doubt that conflicts of interest are pervasive
in our personal as well as our professional lives.
Nevertheless, doing our best for our patients requires that
they trust us absolutely to act always in their best interest.
To maintain the highest level of trust, we must avoid even
the appearance of acting primarily in self-interest, because
the appearance alone is enough to undermine the trust that
is so central to achieving the professional goals of the sur-
geon. Specific ethical guidelines that address conflicts of
interest can be found in the work of the American Medical
Association’s Council on Ethical and Judicial Affairs.13
We have many unavoidable conflicts of interest with
respect to our patients, such as charging fees and honoring
conflicting family obligations. But we violate the trust of
our patients when we generate new conflicts unnecessarily,
for personal gain. They can take many forms: accepting
gifts or trips from companies; participating in joint ventures
with health care organizations; signing draconian managed
care incentive contracts; using new devices prematurely; or
owning stock in device companies whose products we use.
Such violations of trust can lead to many kinds of harms. In
the short term they can sully our reputations and those of
our organizations, interrupt referral lines, or lead to the
emotional pain and expense of lawsuits. The long-term
harm to professionalism, however, is much more damaging,
and the best way to prevent it is to avoid business entangle-
ments entirely. That is the surest way to protect our most
critical yet fragile asset: our professional integrity.
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